Terug Terug

Reasonable Rx Solving the Drug Price Crisis

Name: Reasonable Rx
Author: Stan Finkelstein

Auteur: Stan Finkelstein

Taal: Engels

Afbeeldingen

Artikel vergelijken

Vergelijk met andere artikelen

Bekijk nu

Auteur: Stan Finkelstein Peter Temin

Co-auteur: Peter Temin

Engels
Hardcover
9780132344494
25 januari 2008
188 pagina's

Alle productspecificaties

Samenvatting

A Real Plan for Making Drugs Affordable--and Promoting Innovation, Too This book is a necessity for understanding the pharmaceutical industry. Both the pluses and minuses of the present system are set forth with a judicious combination of historical narrative, economic analysis, and statistical data. The highly original proposals for reform will be a major stimulant to analysis and policy-making. --Kenneth Arrow, Nobel Laureate in Economics, Professor Emeritus, Stanford University This is a timely book by authors who know what they are talking about. They tackle a big problem: rising drug prices that are threatening to overwhelm us all--and especially those with limited or absent health care insurance. Will we drive people overseas for healthcare? Will there be social unrest? This book describes the problem and then offers a solution. Worth a careful read by everyone, pharmaceutical manufacturers and government policymakers especially. --Roger Williams, M.D., Chief Executive Officer of the United States Pharmacopeia and a former senior official of the Food and Drug Administration This book confounds two sets of skeptics: Those who say there's no way to resolve the conflict between the need to fund pharmaceutical research and our desire to keep medicine affordable; and those who think that economics never has anything good to say. --Honorable Barney Frank, Congressman from Massachusetts This book comes at the right time and could become the starting point of discussions, which will eventually lead us into new era in the healthcare care industry. It will without a doubt become a must for insiders of the pharma- and biotech industries. --Dr. Jurgen Drews, retired President of Roche Pharmaceutical Group Global Research Acknowledgments viii About the Authors ix Introduction xi Chapter 1: Drugs and Drug Prices 1 Chapter 2: The American Way to Discover Drugs 21 Chapter 3: The Drug Industry Today 39 Chapter 4: Are Drug Companies Risky? 59 Chapter 5: How Not to Lower Drug Prices 77 Chapter 6: Squandering R & D Resources 103 Chapter 7: How to Lower Drug Prices 129 Appendix: Our Solution in Detail 155 Index 177

Productspecificaties

Inhoud

Taal: en
Bindwijze: Hardcover
Oorspronkelijke releasedatum: 25 januari 2008
Aantal pagina's: 188
Illustraties: Nee

Betrokkenen

Hoofdauteur: Stan Finkelstein
Tweede Auteur: Peter Temin
Co Auteur: Peter Temin
Hoofduitgeverij: Pearson P T R

Vertaling

Originele titel: Finkelstein:Reasonable Rx _c1

Overige kenmerken

Editie: 1
Extra groot lettertype: Nee
Product breedte: 10 mm
Product hoogte: 10 mm
Product lengte: 10 mm
Studieboek: Nee
Verpakking breedte: 159 mm
Verpakking hoogte: 25 mm
Verpakking lengte: 235 mm
Verpakkingsgewicht: 454 g

EAN

EAN: 9780132344494

Je vindt dit artikel in

Categorieën: Economie & Financiën

Geneeskunde & Verpleging

Economie

Boeken
Taal: Engels
Boek, ebook of luisterboek?: Boek
Studieboek of algemeen: Algemene boeken
Beschikbaarheid: Leverbaar

Reviews

Nog geen reviews

Hoe controleren en plaatsen wij reviews? Hoe controleren en plaatsen wij reviews?

Negatief, positief, neutraal: we zetten een review altijd online. We controleren wel eerst of ’ie voldoet aan onze reviewvoorwaarden en niet nep is. We controleren ook of ’ie is geschreven door iemand die het artikel heeft gekocht via bol.com en zetten dit er dan bij. De controles gebeuren automatisch, al kijken er soms mensen mee. Bol.com betaalt niet voor reviews. Als een reviewer door een andere partij is vergoed, staat dit in de review zelf.